The goal of Doloromics is to find better ways to treat chronic pain To achieve this goal, we have two main approaches, both of which use cutting edge computational techniques to analyze genomic sequencing data from human patients: 1. Analyze existing datasets using our proprietary algorithms to identify novel drug-targets 2. Identify biomarkers in chronic pain patients to help identify individualized treatment options